Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 10:48 PM
Study NCT ID:
NCT06283667
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-10-29
First Post:
2024-02-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Special Use - Results Surveillance on Long-term Use With Wegovy®
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009765', 'term': 'Obesity'}], 'ancestors': [{'id': 'D050177', 'term': 'Overweight'}, {'id': 'D044343', 'term': 'Overnutrition'}, {'id': 'D009748', 'term': 'Nutrition Disorders'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D001835', 'term': 'Body Weight'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C000591245', 'term': 'semaglutide'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 1000}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'ENROLLING_BY_INVITATION', 'startDateStruct': {'date': '2024-06-11', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-10', 'completionDateStruct': {'date': '2028-01-31', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-10-27', 'studyFirstSubmitDate': '2024-02-21', 'studyFirstSubmitQcDate': '2024-02-21', 'lastUpdatePostDateStruct': {'date': '2025-10-29', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2024-02-28', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2028-01-31', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Number of Adverse Reactions (ARs)', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured as count of events'}], 'secondaryOutcomes': [{'measure': 'Number of Adverse Events (AEs)', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured as count of events'}, {'measure': 'Number of serious adverse events (SAEs)', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured as count of events'}, {'measure': 'Number of Serious Adverse Reactions (SARs)', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured as count of events'}, {'measure': 'Change in body weight (Percent (%))', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured as percent (%)'}, {'measure': 'Change in body weight (Kilograms (Kg))', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured in kilograms (Kg)'}, {'measure': 'Change in waist circumference', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured in centimeters (cm)'}, {'measure': 'Change in BMI (Body Mass Index)', 'timeFrame': 'From baseline (week 0) to end of study (week 104)', 'description': 'Measured in kilogram per meter square (kg/m\\^2)'}, {'measure': 'Change in body weight after treatment discontinuation', 'timeFrame': 'From treatment discontinuation after at least 12 weeks to end of study (week 104)', 'description': 'Measured as percent (%)'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Obesity']}, 'descriptionModule': {'briefSummary': 'The purpose of the study is to investigate the safety and effectiveness of Wegovy® in patients with obesity disease under real-world clinical practice in Japan. Participants will get Wegovy® as prescribed by the study doctor. The study will last for about 4 years. Participant will be in the study for about 2 years (104 weeks).'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Participants are patients with obesity treated with Wegovy® (semaglutide) once weekly under real-world clinical practice conditions in Japan.', 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol)\n* The decision to initiate treatment with commercially available Wegovy® has been made by the patient/Legally Acceptable Representative (LAR) and the treating physician before and independently from the decision to include the patient in this study\n* Male or female, no age limitation\n* Diagnosis of obesity disease; with either hypertension, dyslipidaemia or type 2 diabetes, insufficiently controlled with diet and exercise therapies, and should meet either of:\n\n 1. Body mass index (BMI)\\* greater than or equal to 27 kilograms per meter square (kg/m\\^2) with two or more obesity-related comorbidities\\*\\*, or\n 2. BMI\\* greater than or equal to 35 kg/m\\^2\n* Participant who has never been exposed to Semaglutide or who started treatment with Wegovy® within the past 4 weeks at registration\n\n * BMI calculation will be based on height and body weight recorded in the enrolment form of electronic case report form (eCRF) at enrolment.\n\n * Definition of obesity-related comorbidities are in accordance with Japan Student Services Organization (JASSO) guideline 3: (1) impaired glucose tolerance, (2) dyslipidaemia, (3) hypertension, (4) hyper-uricemia/gout, (5) coronary artery disease, (6) cerebral infarction, (7) non-alcoholic fatty liver disease, (8) menstrual disorder/infertility, (9) obstructive sleep apnoea syndrome/obesity-hypoventilation syndrome, (10) locomotory disease or (11) obesity-related kidney disease.\n\nExclusion Criteria:\n\n* Previous participation in this study. Participation is defined as having given informed consent in this study\n* Treatment with any investigational drug within 30 days prior to baseline (Visit 1)\n* Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation\n* A history of hypersensitivity to any ingredients of this drug\n* Diabetic ketoacidosis, diabetic coma, pre-coma or type 1 diabetes mellitus \\[The treatment with insulin is mandatory. It is not appropriate to use this drug\\]\n* In emergency cases such as severe infections and surgery in patients with type 2 diabetes \\[It is desirable to control blood glucose with insulin; therefore, administration of this drug is not appropriate\\]\n* Pregnant or possibly pregnant female\n* Female who plans to become pregnant within 2 months'}, 'identificationModule': {'nctId': 'NCT06283667', 'briefTitle': 'Special Use - Results Surveillance on Long-term Use With Wegovy®', 'organization': {'class': 'INDUSTRY', 'fullName': 'Novo Nordisk A/S'}, 'officialTitle': 'A Multi-centre, Prospective, Non-interventional, Single-armed, 104 Weeks Post-marketing Study to Investigate Safety and Clinical Parameters of Wegovy® Once Weekly in Patients With Obesity Disease Under Real-world Clinical Practice Conditions', 'orgStudyIdInfo': {'id': 'NN9536-4872'}, 'secondaryIdInfos': [{'id': 'U1111-1266-3863', 'type': 'OTHER', 'domain': 'World Health Organization (WHO)'}]}, 'armsInterventionsModule': {'armGroups': [{'label': 'Wegovy®', 'description': 'Patients with obesity treated with Wegovy® (semaglutide) once weekly under real-world clinical practice conditions in Japan.', 'interventionNames': ['Drug: Semaglutide']}], 'interventions': [{'name': 'Semaglutide', 'type': 'DRUG', 'otherNames': ['Wegovy®'], 'description': 'Paricipants will be treated with commercially available Wegovy® according to routine clinical practice at the discretion of the treating physician, following approved label in Japan. The decision to initiate treatment with commercially available Wegovy® has been made by the patient and the treating physician before and independently from the decision to participate in this study.', 'armGroupLabels': ['Wegovy®']}]}, 'contactsLocationsModule': {'locations': [{'zip': '100-0005', 'city': 'Tokyo', 'state': 'Chiyoda City', 'country': 'Japan', 'facility': 'Novo Nordisk Investigational Site', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '862-0976', 'city': 'Kumamoto', 'state': 'Kumamoto, Japan', 'country': 'Japan', 'facility': 'Jinnouchi Hospital_Internal Medicine', 'geoPoint': {'lat': 32.80589, 'lon': 130.69181}}, {'zip': '444-8553', 'city': 'Aichi', 'country': 'Japan', 'facility': 'Okazaki City Hospital', 'geoPoint': {'lat': 32.51879, 'lon': 130.62158}}, {'zip': '467-8602', 'city': 'Aichi', 'country': 'Japan', 'facility': 'Nagoya City University Hospital_Obesity Treatment Center', 'geoPoint': {'lat': 32.51879, 'lon': 130.62158}}, {'zip': '470-11-1', 'city': 'Aichi', 'country': 'Japan', 'facility': 'Fujita Health University Hospital_Endocrinology, Diabetes and Metabolism', 'geoPoint': {'lat': 32.51879, 'lon': 130.62158}}, {'zip': '494-0001', 'city': 'Aichi', 'country': 'Japan', 'facility': 'Ichinomiyanishi Hospital', 'geoPoint': {'lat': 32.51879, 'lon': 130.62158}}, {'zip': '010-8577', 'city': 'Akita', 'country': 'Japan', 'facility': 'Nakadori General Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 39.71667, 'lon': 140.11667}}, {'zip': '017-8550', 'city': 'Akita', 'country': 'Japan', 'facility': 'Odate Municipal General Hospital_Endocrinology and Metabolism', 'geoPoint': {'lat': 39.71667, 'lon': 140.11667}}, {'zip': '010-8543', 'city': 'Akita-shi, Akita', 'country': 'Japan', 'facility': 'Akita University Hospital, Diabetes and Endocrinology'}, {'zip': '031-8555', 'city': 'Aomori', 'country': 'Japan', 'facility': 'Hachinohe City Hospital_Diabetes and Metabolism', 'geoPoint': {'lat': 40.81667, 'lon': 140.73333}}, {'zip': '113-8431', 'city': 'Bunkyo-ku, Tokyo', 'country': 'Japan', 'facility': 'Juntendo University Hospital_Tokyo'}, {'zip': '270-0034', 'city': 'Chiba', 'country': 'Japan', 'facility': 'Shinmatsudo Central General Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 35.6, 'lon': 140.11667}}, {'zip': '285-8741', 'city': 'Chiba', 'country': 'Japan', 'facility': 'Toho University Medical Center Sakura Hospital', 'geoPoint': {'lat': 35.6, 'lon': 140.11667}}, {'zip': '292-0822', 'city': 'Chiba', 'country': 'Japan', 'facility': 'Kimitsu Chuo Hospital_Diabetology and Endocrinology', 'geoPoint': {'lat': 35.6, 'lon': 140.11667}}, {'zip': '296-8602', 'city': 'Chiba', 'country': 'Japan', 'facility': 'Kameda Medical Center_Diabetes and Endocrinology', 'geoPoint': {'lat': 35.6, 'lon': 140.11667}}, {'zip': '818-8502', 'city': 'Chikushino-shi, Fukuoka', 'country': 'Japan', 'facility': 'Fukuoka University Chikushi Hospital_Endocrinology and Diabetes Mellitus'}, {'zip': '100-0005', 'city': 'Chiyoda-ku, Tokyo', 'country': 'Japan', 'facility': 'Chiba University Hospital_Diabetes, Metabolism and Endocrinology', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '790-0034', 'city': 'Ehime', 'country': 'Japan', 'facility': 'Mikannohana Clinic'}, {'zip': '790-0067', 'city': 'Ehime', 'country': 'Japan', 'facility': 'Matsuyama Shimin Hospital_Diabetes and Endocrinology'}, {'zip': '910-1193', 'city': 'Fukui', 'country': 'Japan', 'facility': 'University of Fukui Hospital', 'geoPoint': {'lat': 34.84214, 'lon': 135.54836}}, {'zip': '811-3195', 'city': 'Fukuoka', 'country': 'Japan', 'facility': 'National Hospital Organization Fukuokahigashi Medical Center', 'geoPoint': {'lat': 33.6, 'lon': 130.41667}}, {'zip': '813-0044', 'city': 'Fukuoka', 'country': 'Japan', 'facility': 'Fukuoka Kieikai Hospital_Diabetes and obesity centre', 'geoPoint': {'lat': 33.6, 'lon': 130.41667}}, {'zip': '814-0001', 'city': 'Fukuoka', 'country': 'Japan', 'facility': 'Fukuoka Sanno Hospital', 'geoPoint': {'lat': 33.6, 'lon': 130.41667}}, {'zip': '812-8582', 'city': 'Fukuoka-shi, Fukuoka', 'country': 'Japan', 'facility': 'Kyushu University Hospital'}, {'zip': '960-1295', 'city': 'Fukushima', 'country': 'Japan', 'facility': 'Fukushima Medical University Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 37.75, 'lon': 140.46667}}, {'zip': '501-3802', 'city': 'Gifu', 'country': 'Japan', 'facility': 'Chuno Kosei Hospital_Endocrinology and Diabetes', 'geoPoint': {'lat': 35.42291, 'lon': 136.76039}}, {'zip': '501-6062', 'city': 'Gifu', 'country': 'Japan', 'facility': 'Matsunami General Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 35.42291, 'lon': 136.76039}}, {'zip': '503-8502', 'city': 'Gifu', 'country': 'Japan', 'facility': 'Ogaki Municipal Hospital_Diabetes and Nephrology', 'geoPoint': {'lat': 35.42291, 'lon': 136.76039}}, {'zip': '371-8511', 'city': 'Gunma', 'country': 'Japan', 'facility': 'Gunma University Hospital, Dept. of Endocrinology and Diabetes'}, {'zip': '431-3192', 'city': 'Hamamatsu-shi, Shizuoka', 'country': 'Japan', 'facility': 'Hamamatsu University Hospital'}, {'zip': '722-0014', 'city': 'Hiroshima', 'country': 'Japan', 'facility': 'Murakami Memorial Hospital_Diabetes Internal Medicine', 'geoPoint': {'lat': 34.4, 'lon': 132.45}}, {'zip': '735-8585', 'city': 'Hiroshima', 'country': 'Japan', 'facility': 'Mazda Hospital_Diabetes', 'geoPoint': {'lat': 34.4, 'lon': 132.45}}, {'zip': '060-0807', 'city': 'Hokkaido', 'country': 'Japan', 'facility': 'Sapporo Tonyobyo Kojosen Clinic'}, {'zip': '070-8530', 'city': 'Hokkaido', 'country': 'Japan', 'facility': 'Japanese Red Cross Asahikawa Hospital'}, {'zip': '663-8131', 'city': 'Hyōgo', 'country': 'Japan', 'facility': 'Hyogo Medical University Hospital_Diabetes, Endocrinology and Metabolism', 'geoPoint': {'lat': 43.36667, 'lon': 144.43333}}, {'zip': '305-8576', 'city': 'Ibaraki', 'country': 'Japan', 'facility': 'University of Tsukuba Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.81641, 'lon': 135.56828}}, {'zip': '691-8501', 'city': 'Izumo, Shimane', 'country': 'Japan', 'facility': 'Shimane Univ. HP, Dept of Endocrinology&Metabolism'}, {'zip': '890-8520', 'city': 'Kagoshima', 'country': 'Japan', 'facility': 'Kagoshima University Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 31.56667, 'lon': 130.55}}, {'zip': '210-0013', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'Kawasaki Municipal Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '211-8510', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'Kanto Rousai Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '216-0015', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'St. Marianna University School of Medicine Hospital', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '222-0036', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'Yokohama Rosai Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '227-8501', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'Showa University Fujigaoka Hospital_Internal Medicine', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '231-8682', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'Yokohama City Minato Red Cross Hospital_Endocrinology', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '232-0024', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'Yokohama City University Medical Center_Endocrinology and Diabetes', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '259-1193', 'city': 'Kanagawa', 'country': 'Japan', 'facility': 'Tokai University Hospital_Nephrology, Endocrinology and Metabolism', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '232-0024', 'city': 'Kanahawa', 'country': 'Japan', 'facility': 'Yokohama City University Medical Center_Nephrology and Hypertension'}, {'zip': '486-8510', 'city': 'Kasugai-shi, Aichi', 'country': 'Japan', 'facility': 'Kasugai Municipal Hospital_Cardiovascular Medicine', 'geoPoint': {'lat': 32.51879, 'lon': 130.62158}}, {'zip': '211-0063', 'city': 'Kawasaki-shi, Kanagawa-ken', 'country': 'Japan', 'facility': 'Nippon Medical School Musashikosugi Hospital_Neurological Surgery'}, {'zip': '783-8505', 'city': 'Kochi', 'country': 'Japan', 'facility': 'Kochi Medical School Hospital_Endocrinology, Metabolism and Nephrology', 'geoPoint': {'lat': 33.55, 'lon': 133.53333}}, {'zip': '866-8660', 'city': 'Kumamoto', 'country': 'Japan', 'facility': 'Kumamoto General Hospital_Diabetes Center', 'geoPoint': {'lat': 32.80589, 'lon': 130.69181}}, {'zip': '867-0041', 'city': 'Kumamoto', 'country': 'Japan', 'facility': 'Minamata City General Hospital & Medical Center_Metabolism', 'geoPoint': {'lat': 32.80589, 'lon': 130.69181}}, {'zip': '860-0811', 'city': 'Kumamoto-shi, Kumamoto', 'country': 'Japan', 'facility': 'Kumamoto University Hospital, Diabetes, Metabo and Endo'}, {'zip': '737-0023', 'city': 'Kure-shi, Hiroshima', 'country': 'Japan', 'facility': 'Kure Medical Center and Chugoku Cancer Center', 'geoPoint': {'lat': 34.4, 'lon': 132.45}}, {'zip': '830 8577', 'city': 'Kurume-shi, Fukuoka', 'country': 'Japan', 'facility': 'Shin Koga Hospital', 'geoPoint': {'lat': 33.6, 'lon': 130.41667}}, {'zip': '602-8566', 'city': 'Kyoto', 'country': 'Japan', 'facility': 'University Hospital Kyoto Prefectual University of Medicine', 'geoPoint': {'lat': 35.02107, 'lon': 135.75385}}, {'zip': '604-8845', 'city': 'Kyoto', 'country': 'Japan', 'facility': 'Kyoto City Hospital_Diabetes and Metabolism', 'geoPoint': {'lat': 35.02107, 'lon': 135.75385}}, {'zip': '606-8507', 'city': 'Kyoto-shi, Kyoto', 'country': 'Japan', 'facility': 'Kyoto University Hospital'}, {'zip': '612-8555', 'city': 'Kyoto-shi, Kyoto', 'country': 'Japan', 'facility': 'National Hospital Organization Kyoto Medical Center_Cardiology'}, {'zip': '514-8507', 'city': 'Mie', 'country': 'Japan', 'facility': 'Mie University Hospital_Mie', 'geoPoint': {'lat': 32.96667, 'lon': 131.58333}}, {'zip': '516-8512', 'city': 'Mie', 'country': 'Japan', 'facility': 'Japanese Red Cross Ise Hospital_Diabetes and Metabolism', 'geoPoint': {'lat': 32.96667, 'lon': 131.58333}}, {'zip': '238-0101', 'city': 'Miura-shi, Kanagawa', 'country': 'Japan', 'facility': 'Miura Central Clinic', 'geoPoint': {'lat': 37.58333, 'lon': 139.91667}}, {'zip': '480-1195', 'city': 'Nagakute-shi, Aichi', 'country': 'Japan', 'facility': 'Aichi Medical University Hospital, Diabetes Medicine', 'geoPoint': {'lat': 32.51879, 'lon': 130.62158}}, {'zip': '381-1231', 'city': 'Nagano', 'country': 'Japan', 'facility': 'Nagano Matsushiro General Hospital_department of diet', 'geoPoint': {'lat': 36.65, 'lon': 138.18333}}, {'zip': '903-0125', 'city': 'Nakagami-gun, Okinawa-ken', 'country': 'Japan', 'facility': 'University of the Ryukyus Hospital'}, {'zip': '020-8505', 'city': 'Numakunai', 'country': 'Japan', 'facility': 'Iwate Medical University Uchimaru Medical Center, Division of Diabetes and Metabolism and Endocrine medicine', 'geoPoint': {'lat': 39.96667, 'lon': 141.21667}}, {'zip': '700-0914', 'city': 'Okayama', 'country': 'Japan', 'facility': 'Okayama University Hospital_Neph. and Diabetes, Metabolism', 'geoPoint': {'lat': 34.65, 'lon': 133.93333}}, {'zip': '702-8055', 'city': 'Okayama', 'country': 'Japan', 'facility': 'Okayama Rosai Hospital_Cardiology', 'geoPoint': {'lat': 34.65, 'lon': 133.93333}}, {'zip': '701-1192', 'city': 'Okayama-shi, Okayama', 'country': 'Japan', 'facility': 'Okayama Medical Center_Cardiology'}, {'zip': '901-2102', 'city': 'Okinawa', 'country': 'Japan', 'facility': 'Urasoe General Hospital_Cardiology', 'geoPoint': {'lat': 26.33583, 'lon': 127.80139}}, {'zip': '540-0006', 'city': 'Osaka', 'country': 'Japan', 'facility': 'Osaka National Hospital_Osaka', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '545-0051', 'city': 'Osaka', 'country': 'Japan', 'facility': 'Osaka Metropolitan University Hospital_Lifestyle disease diabetes centre', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '555-0034', 'city': 'Osaka', 'country': 'Japan', 'facility': 'Chibune Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '570-8540', 'city': 'Osaka', 'country': 'Japan', 'facility': 'Matsushita Memorial Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '596-8501', 'city': 'Osaka', 'country': 'Japan', 'facility': 'Kishiwada City Hospital_Endocrinology and Metabolism', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '599-8247', 'city': 'Osaka', 'country': 'Japan', 'facility': 'Bellland Sogo Byoin_Endocrinology and Metabolism', 'geoPoint': {'lat': 34.69379, 'lon': 135.50107}}, {'zip': '534-0021', 'city': 'Osaka-shi, Osaka', 'country': 'Japan', 'facility': 'Osaka City General Hospital_Endocrinology and Diabetes Mellitus'}, {'zip': '989-6183', 'city': 'Osaki-shi, Miyagi', 'country': 'Japan', 'facility': 'Osaki citizen hospital_Diabetes and metabolic disease', 'geoPoint': {'lat': 26.62566, 'lon': 128.18236}}, {'zip': '874-8538', 'city': 'Ōita', 'country': 'Japan', 'facility': 'Shinbeppu Hospital_Endocrinology and Metabolism', 'geoPoint': {'lat': 33.23333, 'lon': 131.6}}, {'zip': '847-8588', 'city': 'Saga', 'country': 'Japan', 'facility': 'Karatsu Redcross Hospital_Diabetes Internal Medicine', 'geoPoint': {'lat': 33.23333, 'lon': 130.3}}, {'zip': '060-8648', 'city': 'Sapporo, Hokkaido', 'country': 'Japan', 'facility': 'NTT East Japan Sapporo HP_Diabetes Mellitus & Int med Endo', 'geoPoint': {'lat': 43.06667, 'lon': 141.35}}, {'zip': '060-8543', 'city': 'Sapporo-shi, Hokkaido', 'country': 'Japan', 'facility': 'Sapporo Medical University Hospital_Cardiovascular, Kidney, Metabolism Endocrinology', 'geoPoint': {'lat': 43.06667, 'lon': 141.35}}, {'zip': '410-0041', 'city': 'Shizuoka', 'country': 'Japan', 'facility': 'Aso Clinic', 'geoPoint': {'lat': 34.98333, 'lon': 138.38333}}, {'zip': '410-2295', 'city': 'Shizuoka', 'country': 'Japan', 'facility': 'Juntendo University Shizuoka Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.98333, 'lon': 138.38333}}, {'zip': '430-0929', 'city': 'Shizuoka', 'country': 'Japan', 'facility': 'JA Shizuoka Kohseiren Enshu Hospital_Internal Medicine', 'geoPoint': {'lat': 34.98333, 'lon': 138.38333}}, {'zip': '432-8580', 'city': 'Shizuoka', 'country': 'Japan', 'facility': 'Hamamatsu Medical Center', 'geoPoint': {'lat': 34.98333, 'lon': 138.38333}}, {'zip': '434-8533', 'city': 'Shizuoka', 'country': 'Japan', 'facility': 'Japanese Red Cross Hamamatsu Hospital_Cardiology', 'geoPoint': {'lat': 34.98333, 'lon': 138.38333}}, {'zip': '436-8555', 'city': 'Shizuoka', 'country': 'Japan', 'facility': 'Chutoen General Medical Center_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.98333, 'lon': 138.38333}}, {'zip': '326-0053', 'city': 'Tochigi', 'country': 'Japan', 'facility': 'Nagasaki Hospital_Internal Medicine', 'geoPoint': {'lat': 36.38333, 'lon': 139.73333}}, {'zip': '327-8511', 'city': 'Tochigi', 'country': 'Japan', 'facility': 'Sano Kosei General Hospital_Neph.& Endocrinology,Metab.', 'geoPoint': {'lat': 36.38333, 'lon': 139.73333}}, {'zip': '779-3125', 'city': 'Tokushima', 'country': 'Japan', 'facility': 'Tamaki Aozora Byoin_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.06667, 'lon': 134.56667}}, {'zip': '100-0005', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Gifu University Hospital', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '101-8309', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Nihon University Hospital_Internal Medicine', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '102-8798', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Tokyo Teishin Hospital', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '103-0027', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Nihonbashi Leiwa Naika Clinic', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '105-8471', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'The Jikei University Hospital Dept of Diabetes, Metabolic', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '113-8519', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Institute of Science Tokyo Hospital_Cardiology', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '157-8535', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'National Center for Child Health and Development_Internal medicine for women', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '160-8582', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Keio University Hospital', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '162-0054', 'city': 'Tokyo', 'country': 'Japan', 'facility': "Tokyo Women's Medical University_Diabetes and Metabolism", 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '181-8611', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Kyorin University Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '183-8524', 'city': 'Tokyo', 'country': 'Japan', 'facility': 'Tokyo Metropolitan Tama Medical Center', 'geoPoint': {'lat': 35.6895, 'lon': 139.69171}}, {'zip': '683-8504', 'city': 'Tottori', 'country': 'Japan', 'facility': 'Tottori University Hospital_Endocrinology and Metabolism', 'geoPoint': {'lat': 34.24877, 'lon': 134.67796}}, {'zip': '683-8504', 'city': 'Tottori', 'country': 'Japan', 'facility': 'Tottori University Hospital_Pharmacotherapy', 'geoPoint': {'lat': 34.24877, 'lon': 134.67796}}, {'zip': '441-8085', 'city': 'Toyohashi-shi, Aichi-ken', 'country': 'Japan', 'facility': 'Toyohashi Municipal Hospital', 'geoPoint': {'lat': 34.76667, 'lon': 137.38333}}, {'zip': '640-8558', 'city': 'Wakayama', 'country': 'Japan', 'facility': 'Japanese Red Cross Wakayama Medical Center_Diabetology and Endocrinology', 'geoPoint': {'lat': 34.23333, 'lon': 135.16667}}, {'zip': '641-8510', 'city': 'Wakayama', 'country': 'Japan', 'facility': 'Wakayama Medical Univercity Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.23333, 'lon': 135.16667}}, {'zip': '990-9585', 'city': 'Yamagata-shi, Yamagata', 'country': 'Japan', 'facility': 'Yamagata University Hospital, Internal Medicine 3'}, {'zip': '750-0061', 'city': 'Yamaguchi', 'country': 'Japan', 'facility': 'Shimonoseki Medical Center_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.18333, 'lon': 131.46667}}, {'zip': '756-0095', 'city': 'Yamaguchi', 'country': 'Japan', 'facility': 'Yamaguchi Rosai Hospital_Diabetes and Endocrinology', 'geoPoint': {'lat': 34.18333, 'lon': 131.46667}}, {'zip': '236-0004', 'city': 'Yokohama, Kanagawa', 'country': 'Japan', 'facility': 'Yokohama City University Hospital, Endocrinology, Metabolism'}, {'facility': 'Tokyo Medical Univ. Hospital_Diabetes, Metabolism and Endocrinology'}], 'overallOfficials': [{'name': 'Clinical Transparency (dept. 2834)', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Novo Nordisk A/S'}]}, 'ipdSharingStatementModule': {'url': 'http://novonordisk-trials.com', 'ipdSharing': 'YES', 'description': 'According to the Novo Nordisk disclosure commitment on novonordisk-trials.com'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Novo Nordisk A/S', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}